Full Story, Every View.
Published loading...Updated

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Bought by Price T Rowe Associates Inc. MD

Summary by defenseworld.net
Price T Rowe Associates Inc. MD lifted its position in shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH – Free Report) by 21.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 9,468 shares of the company’s stock after buying an additional 1,647 shares during the period. Price T Rowe Associates Inc. MD’s holdings in Dianthus Therapeutics were worth $207,000 …

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

reporter.am broke the news in on Friday, May 16, 2025.
Sources are mostly out of (0)